Clinical Protocols and Guidelines
These guidelines and clinical protocols have been developed by the Access and Integration Drug Management Programme in collaboration with clinical experts
- HSE Prescribing Protocol for Crohn’s Disease - Risankizumab (Skyrizi) (PDF, size 238.5 KB, 4 pages)
- HSE Prescribing Protocol for Ulcerative Colitis - Risankizumab (Skyrizi) and Mirikizumab (Omvoh) (PDF, size 242.3 KB, 4 pages)
- HSE Prescribing Guideline for Andexanet Alfa (PDF, size 674 KB, 8 pages)
- COVID-19
- Multiple Sclerosis
- Enzyme Replacement Therapy
- Rare Diseases
- Severe Refractory Eosinophilic Asthma
- AIDMP Guidelines